Sumitomo Pharma Co Ltd
TSE:4506
Sumitomo Pharma Co Ltd
Selling, General & Administrative
Sumitomo Pharma Co Ltd
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sumitomo Pharma Co Ltd
TSE:4506
|
Selling, General & Administrative
-¥277.7B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Selling, General & Administrative
-¥1.1T
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Selling, General & Administrative
-¥637B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-3%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Selling, General & Administrative
-¥845.5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Selling, General & Administrative
-¥114.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
Astellas Pharma Inc
TSE:4503
|
Selling, General & Administrative
-¥740.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-6%
|
See Also
What is Sumitomo Pharma Co Ltd's Selling, General & Administrative?
Selling, General & Administrative
-277.7B
JPY
Based on the financial report for Dec 31, 2023, Sumitomo Pharma Co Ltd's Selling, General & Administrative amounts to -277.7B JPY.
What is Sumitomo Pharma Co Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-5%
Over the last year, the Selling, General & Administrative growth was 6%. The average annual Selling, General & Administrative growth rates for Sumitomo Pharma Co Ltd have been -11% over the past three years , -7% over the past five years , and -5% over the past ten years .